跳至主要内容
临床试验/ISRCTN63484804
ISRCTN63484804已完成3 期

Intravenous versus oral iron for iron deficiency anaemia in pregnant Nigerian women (IVON): an open label, randomized controlled trial

niversity of Lagos0 个研究点目标入组 1,056 人开始时间: 2020年12月10日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
1,056

研究概览

简要总结

2022 Protocol article in https://pubmed.ncbi.nlm.nih.gov/36076211/ (added 09/09/2022) 2024 Other publications in https://pubmed.ncbi.nlm.nih.gov/38347614/ Qualitative study (added 13/02/2024)

研究设计

研究类型
Interventional

入排标准

性别
Female

入选标准

  • 1. Pregnant women aged 15 to 49 years old between 20- and 32-weeks’ gestational age
  • 2. Baseline (enrolment) laboratory-confirmed moderate or severe anemia (Hb <10 g/dl)

排除标准

  • Current exclusion criteria as of 27/06/2022:
  • 1. Medically confirmed significant bleeding, major surgery or received blood transfusion within the last 3 months.
  • 2. Severe symptomatic anemia needing urgent correction with blood transfusion.
  • 3. Anemia of other cause besides IDA e.g., Sickle cell anemia.
  • 4. Clinically confirmed malabsorption syndrome.
  • 5. Hypersensitivity to any form of iron treatment.
  • 6. History of any immune related illness e.g., SLE, Rheumatoid arthritis.
  • 7. Preexisting maternal depression or other psychiatric illness.
  • 8. Severe allergic reactions such as severe asthma.
  • 9. History of severe drug allergy.
  • Previous exclusion criteria:
  • 1. Medically confirmed significant bleeding, major surgery or received a blood transfusion within the last 3 months
  • 2. Symptomatic anaemia with dyspnea or fatigue and a need for urgent correction
  • 3. Concurrent anaemia of another cause besides IDA
  • 4. Clinically-confirmed malabsorption syndrome or hypersensitivity to any form of iron treatment
  • 5. Preexisting maternal depression or other psychiatric illness

研究者

发起方
niversity of Lagos

相似试验